Ibrutinib and Venetoclax for First-Line Treatment of CLL
Jain, Nitin, Keating, Michael, Thompson, Philip, Ferrajoli, Alessandra, Burger, Jan, Borthakur, Gautam, Takahashi, Koichi, Estrov, Zeev, Fowler, Nathan, Kadia, Tapan, Konopleva, Marina, Alvarado, Yesid, Yilmaz, Musa, DiNardo, Courtney, Bose, Prithviraj, Ohanian, Maro, Pemmaraju, Naveen, Jabbour, Elias, Sasaki, Koji, Kanagal-Shamanna, Rashmi, Patel, Keyur, Jorgensen, Jeffrey, Garg, Naveen, Wang, Xuemei, Sondermann, Katrina, Cruz, Nichole, Wei, Chongjuan, Ayala, Ana, Plunkett, William, Kantarjian, Hagop, Gandhi, Varsha, Wierda, William
Published in The New England journal of medicine (30.05.2019)
Published in The New England journal of medicine (30.05.2019)
Get full text
Journal Article
Long‐term follow‐up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic‐phase chronic myeloid leukemia
Naqvi, Kiran, Jabbour, Elias, Skinner, Jeffrey, Anderson, Kristin, Dellasala, Sara, Yilmaz, Musa, Ferrajoli, Alessandra, Bose, Prithviraj, Thompson, Philip, Alvarado, Yesid, Jain, Nitin, Takahashi, Koichi, Burger, Jan, Estrov, Zeev, Borthakur, Gautam, Pemmaraju, Naveen, Paul, Shilpa, Cortes, Jorge, Kantarjian, Hagop M.
Published in Cancer (01.01.2020)
Published in Cancer (01.01.2020)
Get full text
Journal Article
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
Jabbour, Elias, Short, Nicholas J., Montalban-Bravo, Guillermo, Huang, Xuelin, Bueso-Ramos, Carlos, Qiao, Wei, Yang, Hui, Zhao, Chong, Kadia, Tapan, Borthakur, Gautam, Pemmaraju, Naveen, Sasaki, Koji, Estrov, Zeev, Cortes, Jorge, Ravandi, Farhad, Alvarado, Yesid, Komrokji, Rami, Sekeres, Mikkael A., Steensma, David P., DeZern, Amy, Roboz, Gail, Kantarjian, Hagop, Garcia-Manero, Guillermo
Published in Blood (28.09.2017)
Published in Blood (28.09.2017)
Get full text
Journal Article
Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic‐phase chronic myeloid leukemia
Naqvi, Kiran, Jabbour, Elias, Skinner, Jeffrey, Yilmaz, Musa, Ferrajoli, Alessandra, Bose, Prithviraj, Thompson, Philip, Alvarado, Yesid, Jain, Nitin, Takahashi, Koichi, Burger, Jan, Estrov, Zeev, Borthakur, Gautam, Pemmaraju, Naveen, Paul, Shilpa, Cortes, Jorge, Kantarjian, Hagop M.
Published in Cancer (01.07.2018)
Published in Cancer (01.07.2018)
Get full text
Journal Article
A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia
Bose, Prithviraj, Verstovsek, Srdan, Cortes, Jorge E, Tse, Susan, Gasior, Yvonne, Jain, Nitin, Jabbour, Elias J, Estrov, Zeev, Alvarado, Yesid, DiNardo, Courtney D, Pemmaraju, Naveen, Kornblau, Steven M, Kadia, Tapan M, Daver, Naval G, Naqvi, Kiran, Short, Nicholas J, Masarova, Lucia, Villareal, John, Pierce, Sherry A, Nogueras-Gonzalez, Graciela, Huang, Xuelin, Garcia-Manero, Guillermo, Kantarjian, Hagop M, Ravandi, Farhad
Published in Leukemia (01.09.2020)
Published in Leukemia (01.09.2020)
Get full text
Journal Article
A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome
Swaminathan, Mahesh, Kantarjian, Hagop M, Levis, Mark, Guerra, Veronica, Borthakur, Gautam, Alvarado, Yesid, DiNardo, Courtney D, Kadia, Tapan, Garcia-Manero, Guillermo, Ohanian, Maro, Daver, Naval, Konopleva, Marina, Pemmaraju, Naveen, Ferrajoli, Alessandra, Andreeff, Michael, Jain, Nitin, Estrov, Zeev, Jabbour, Elias J, Wierda, William G, Pierce, Sherry, Pinsoy, Maria Rhona, Xiao, Lianchun, Ravandi, Farhad, Cortes, Jorge E
Published in Haematologica (Roma) (01.08.2021)
Published in Haematologica (Roma) (01.08.2021)
Get full text
Journal Article
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
Reville, Patrick K, Kantarjian, Hagop M, Ravandi, Farhad, Jabbour, Elias, DiNardo, Courtney D, Daver, Naval, Pemmaraju, Naveen, Ohanian, Maro, Alvarado, Yesid, Xiao, Lianchun, Alatrash, Gheath, Loghavi, Sanam, Rausch, Caitlin R, Borthakur, Gautam, Konopleva, Marina, Cortes, Jorge, Kadia, Tapan M
Published in Blood cancer journal (New York) (17.03.2021)
Published in Blood cancer journal (New York) (17.03.2021)
Get full text
Journal Article
Outcomes and genetic dynamics of acute myeloid leukemia at first relapse
Bataller, Alex, Kantarjian, Hagop, Bazinet, Alexandre, Kadia, Tapan, Daver, Naval, DiNardo, Courtney D, Borthakur, Gautam, Loghavi, Sanam, Patel, Keyur, Tang, Guilin, Sasaki, Koji, Short, Nicholas J, Yilmaz, Musa, Issa, Ghayas C, Alvarado, Yesid, Montalban-Bravo, Guillermo, Maiti, Abhishek, Abbas, Hussein A, Takahashi, Koichi, Pierce, Sherry, Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad
Published in Haematologica (Roma) (02.05.2024)
Published in Haematologica (Roma) (02.05.2024)
Get full text
Journal Article
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia
Kantarjian, Hagop, Haddad, Fadi G, Jain, Nitin, Sasaki, Koji, Short, Nicholas J, Loghavi, Sanam, Kanagal-Shamanna, Rashmi, Jorgensen, Jeffrey, Khouri, Issa, Kebriaei, Partow, Alvarado, Yesid, Kadia, Tapan, Paul, Shilpa, Garcia-Manero, Guillermo, Dabaja, Bouthaina, Yilmaz, Musa, Jacob, Jovitta, Garris, Rebecca, O'Brien, Susan, Ravandi, Farhad, Jabbour, Elias
Published in Journal of hematology and oncology (02.05.2023)
Published in Journal of hematology and oncology (02.05.2023)
Get full text
Journal Article
Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
Bannon, Sarah A, Routbort, Mark J, Montalban-Bravo, Guillermo, Mehta, Rohtesh S, Jelloul, Fatima Zahra, Takahashi, Koichi, Daver, Naval, Oran, Betul, Pemmaraju, Naveen, Borthakur, Gautam, Naqvi, Kiran, Issa, Ghayas, Sasaki, Koji, Alvarado, Yesid, Kadia, Tapan M, Konopleva, Marina, Shamanna, Rashmi Kanagal, Khoury, Joseph D, Ravandi, Farhad, Champlin, Richard, Kantarjian, Hagop M, Bhalla, Kapil, Garcia-Manero, Guillermo, Patel, Keyur P, DiNardo, Courtney D
Published in Frontiers in oncology (28.01.2021)
Published in Frontiers in oncology (28.01.2021)
Get full text
Journal Article
Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes
Montalban-Bravo, Guillermo, Kanagal-Shamanna, Rashmi, Benton, Christopher B., Class, Caleb A., Chien, Kelly S., Sasaki, Koji, Naqvi, Kiran, Alvarado, Yesid, Kadia, Tapan M., Ravandi, Farhad, Daver, Naval, Takahashi, Koichi, Jabbour, Elias, Borthakur, Gautham, Pemmaraju, Naveen, Konopleva, Marina, Soltysiak, Kelly A., Pierce, Sherry R., Bueso-Ramos, Carlos E., Patel, Keyur P., Kantarjian, Hagop, Garcia-Manero, Guillermo
Published in Blood advances (11.02.2020)
Published in Blood advances (11.02.2020)
Get full text
Journal Article
Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study
Bose, Prithviraj, Masarova, Lucia, Pemmaraju, Naveen, Bledsoe, Sharon D, Daver, Naval G, Jabbour, Elias J, Kadia, Tapan M, Estrov, Zeev, Kornblau, Steven M, Andreeff, Michael, Jain, Nitin, Cortes, Jorge E, Borthakur, Gautam, Alvarado, Yesid, Richie, Mary Ann, Dobbins, Mackenzie H, McCrackin, Selene A, Zhou, Lingsha, Pierce, Sherry A, Wang, Xuemei, Pike, Allison M, Garcia-Manero, Guillermo, Kantarjian, Hagop M, Verstovsek, Srdan
Published in Haematologica (Roma) (04.04.2024)
Published in Haematologica (Roma) (04.04.2024)
Get full text
Journal Article
Combination of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia: Early results from a phase II study
Short, Nicholas James, Kantarjian, Hagop M., Konopleva, Marina, Jain, Nitin, Huang, Xuelin, Ravandi, Farhad, Wierda, William G., Borthakur, Gautam, Sasaki, Koji, Issa, Ghayas C., Alvarado, Yesid, Pemmaraju, Naveen, Garcia-Manero, Guillermo, Thankachan, Jennifer, Garris, Rebecca, Jabbour, Elias
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality
Issa, Ghayas C, Kantarjian, Hagop M, Xiao, Lianchun, Ning, Jing, Alvarado, Yesid, Borthakur, Gautam, Daver, Naval, DiNardo, Courtney D, Jabbour, Elias, Bose, Prithviraj, Jain, Nitin, Kadia, Tapan M, Naqvi, Kiran, Pemmaraju, Naveen, Takahashi, Koichi, Verstovsek, Srdan, Andreeff, Micheal, Kornblau, Steven M, Estrov, Zeev, Ferrajoli, Alessandra, Garcia-Manero, Guillermo, Ohanian, Maro, Wierda, William G, Ravandi, Farhad, Cortes, Jorge E
Published in Leukemia (01.11.2020)
Published in Leukemia (01.11.2020)
Get full text
Journal Article
Phase 2 study of hyper‐CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia
Sasaki, Koji, Kantarjian, Hagop, Wierda, William, Ravandi‐Kashani, Farhad, Jorgensen, Jeffrey, Wang, Sa A., Khoury, Joseph, Daver, Naval, Burger, Jan, Di Nardo, Courtney D., Jain, Nitin, Short, Nicholas J., Estrov MD, Zeev, Konopleva MD, PhD, Marina, Ohanian DO, Maro, Garcia‐Manero, Guillermo, Kadia, Tapan, Alvarado‐Valero, Yesid, Yilmaz, Musa, Pierce, Sherry, Garris, Rebecca, Ingram, April, Cortes, Jorge, OʼBrien, Susan, Jabbour, Elias
Published in American journal of hematology (01.07.2020)
Published in American journal of hematology (01.07.2020)
Get full text
Journal Article
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
Short, Nicholas J, Muftuoglu, Muharrem, Ong, Faustine, Nasr, Lewis, Macaron, Walid, Montalban-Bravo, Guillermo, Alvarado, Yesid, Basyal, Mahesh, Daver, Naval, Dinardo, Courtney D, Borthakur, Gautam, Jain, Nitin, Ohanian, Maro, Jabbour, Elias, Issa, Ghayas C, Qiao, Wei, Huang, Xuelin, Kanagal-Shamanna, Rashmi, Patel, Keyur P, Bose, Prithviraj, Ravandi, Farhad, Delumpa, Ricardo, Abramova, Regina, Garcia-Manero, Guillermo, Andreeff, Michael, Cortes, Jorge, Kantarjian, Hagop
Published in Journal of hematology and oncology (08.07.2023)
Published in Journal of hematology and oncology (08.07.2023)
Get full text
Journal Article
Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Boddu, Prajwal, Borthakur, Gautam, Koneru, Mythili, Huang, Xuelin, Naqvi, Kiran, Wierda, William, Bose, Prithviraj, Jabbour, Elias, Estrov, Zeev, Burger, Jan, Alvarado, Yesid, Deshmukh, April, Patel, Ami, Cavazos, Antonio, Han, Lina, Cortes, Jorge E, Kantarjian, Hagop, Andreeff, Michael, Konopleva, Marina
Published in Frontiers in oncology (24.09.2018)
Published in Frontiers in oncology (24.09.2018)
Get full text
Journal Article
Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens
Maiti, Abhishek, Rausch, Caitlin R, Cortes, Jorge E, Pemmaraju, Naveen, Daver, Naval G, Ravandi, Farhad, Garcia-Manero, Guillermo, Borthakur, Gautam, Naqvi, Kiran, Ohanian, Maro, Short, Nicholas J, Alvarado, Yesid, Kadia, Tapan M, Takahashi, Koichi, Yilmaz, Musa, Jain, Nitin, Kornblau, Steven, Montalban Bravo, Guillermo, Sasaki, Koji, Andreeff, Michael, Bose, Prithiviraj, Ferrajoli, Alessandra, Issa, Ghayas C, Jabbour, Elias J, Masarova, Lucia, Thompson, Philip A, Wang, Sa, Konoplev, Sergej, Pierce, Sherry A, Ning, Jing, Qiao, Wei, Welch, John S, Kantarjian, Hagop M, DiNardo, Courtney D, Konopleva, Marina Y
Published in Haematologica (Roma) (01.03.2021)
Published in Haematologica (Roma) (01.03.2021)
Get full text
Journal Article
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents
Hammond, Danielle, Loghavi, Sanam, Wang, Sa A, Konopleva, Marina Y, Kadia, Tapan M, Daver, Naval G, Ohanian, Maro, Issa, Ghayas C, Alvarado, Yesid, Short, Nicholas J, Sasaki, Koji, Pemmaraju, Naveen, Montalban-Bravo, Guillermo, Lachowiez, Curtis A, Maiti, Abhishek, Garcia-Manero, Guillermo, Jabbour, Elias J, Borthakur, Gautam, Ravandi, Farhad, Takahashi, Koichi, Pierce, Sherry R, Kantarjian, Hagop M, DiNardo, Courtney D
Published in Blood cancer journal (New York) (21.09.2023)
Published in Blood cancer journal (New York) (21.09.2023)
Get full text
Journal Article